tetano
Editor, Senior Moderator
Curr Infect Dis Rep. 2012 Apr 3. [Epub ahead of print]
Recent Advances in the Diagnosis and Treatment of Influenza Pneumonia.
Marzoratti L, Iannella HA, G?mez VF, Figueroa SB.
Source
CEMIT (Centro M?dico Investigadores Tucum?n), San Miguel de Tucum?n, Tucum?n, Argentina, luciamarzoratti@gmail.com.
Abstract
A potentially fatal complication of influenza infection is the development of pneumonia, caused either directly by the influenza virus, or by secondary bacterial infection. Pneumonia related to the 2009 influenza A pandemic was found to be underestimated by commonly used pneumonia severity scores in many cases, and to be rapidly progressive, leading to respiratory failure. Confirmation of etiology by laboratory testing is warranted in such cases. Rapid antigen and immunofluorescence testing are useful screening tests, but have limited sensitivity. Confirmation of pandemic H1N1 influenza A infection can only be made by real-time reverse-transcriptase polymerase chain reaction (rRT-PCR) or viral culture. The most effective preventive measure is annual influenza vaccination in selected individuals. Decisions to administer antiviral medications for influenza treatment or chemoprophylaxis should be based upon clinical and epidemiological factors, and should not be delayed by confirmatory laboratory testing results. Neuraminidase inhibitors (NI) are the agents of choice.
PMID:
22477036
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/22477036
Recent Advances in the Diagnosis and Treatment of Influenza Pneumonia.
Marzoratti L, Iannella HA, G?mez VF, Figueroa SB.
Source
CEMIT (Centro M?dico Investigadores Tucum?n), San Miguel de Tucum?n, Tucum?n, Argentina, luciamarzoratti@gmail.com.
Abstract
A potentially fatal complication of influenza infection is the development of pneumonia, caused either directly by the influenza virus, or by secondary bacterial infection. Pneumonia related to the 2009 influenza A pandemic was found to be underestimated by commonly used pneumonia severity scores in many cases, and to be rapidly progressive, leading to respiratory failure. Confirmation of etiology by laboratory testing is warranted in such cases. Rapid antigen and immunofluorescence testing are useful screening tests, but have limited sensitivity. Confirmation of pandemic H1N1 influenza A infection can only be made by real-time reverse-transcriptase polymerase chain reaction (rRT-PCR) or viral culture. The most effective preventive measure is annual influenza vaccination in selected individuals. Decisions to administer antiviral medications for influenza treatment or chemoprophylaxis should be based upon clinical and epidemiological factors, and should not be delayed by confirmatory laboratory testing results. Neuraminidase inhibitors (NI) are the agents of choice.
PMID:
22477036
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/22477036